HTF Market Intelligence released a new research report of 28 pages on title 'Sygnis AG (LIO1) - Pharmaceuticals & Healthcare - Deals and Alliances Profile' with detailed analysis, forecast and strategies.

Summary

Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a biopharmaceutical company that develops novel products and tools in fields of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its products include single cell WGA kits, WGA kits, RCA kit, one step RT-PCR kit, one step RT-qPCR kit, and others. Sygnis offers products such as single cell reverse transcriptase RNaseH+ and RNaseH-. The company’s single cell WGA kit is based on its proprietary primpol technology. Its products are also based on retrotranscriptase technology. The company has presence in Germany and Spain. Sygnis is headquartered in Heidelberg, Germany.

Make an enquiry before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/254138-sygnis-ag-1

Sygnis AG (LIO1) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

The derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.


View Detailed Table of Content @ https://www.htfmarketreport.com/reports/254138-sygnis-ag-1

Table of Contents

List of Figures 4
Sygnis AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sygnis AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sygnis AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sygnis AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sygnis AG, Medical Devices Deals, 2011 to YTD 2017 9
Sygnis AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sygnis AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Cenix BioScience Enters Into Research Agreement With Sygnis Bioscience 11
Licensing Agreements 11
SYGNIS Enters into Licensing Agreement with European Collection of Authenticated Cell Cultures 11
……..Continued

Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=254138

Contact Us:
CRAIG FRANCIS (PR & Marketing Manager)
[email protected]
Ph: +1 (206) 317 1218